BOSTON SCIENTIFIC CORP (BSX) Options Risk Score
Real-time risk analysis for BSX options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full BSX options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan BSX Now — Free →
Is it risky to sell options on BOSTON SCIENTIFIC CORP (BSX) right now?
BOSTON SCIENTIFIC CORP (BSX) currently scores 70 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. That score is driven by 7 recent news items, 5 active legal filings and 27 clinical-trial catalysts falling inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on BSX is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
BSX shows an IV Rank of 64, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 53%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BSX.
BSX's next earnings date is 2026-07-29, outside the near-term options window.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer